Tuesday, April 13, 2021

US Calls For Pause On Johnson & Johnson COVID-19 "Vaccine" KILL SHOTS Due To Deadly Blood Clots!

 I am once again very busy this week with a LOT of personal and work business... I will do my best to fire off articles at this blog every chance I can, so please bear with me!

By this time, most everyone is aware of the dangerous and deadly adverse effects from the AstraZeneca KILL SHOTS of deadly poison that those pricks are still trying to pass off as 'vaccines'.... These jabs of certain death have already been linked to horrific blood clotting problems in Europe and elsewhere across the planet, and therefore there was supposed to be a 'halt' on giving everyone these kill shots until that issue was finally cleared up... Well, several weeks after the first reports about AstraZeneca's poison causing blood clotting, that criminal Pharmaceutical giant is back distributing its garbage around the world, and most nations' so called 'health experts' have cleared AstraZeneca of any wrong doing, and these pricks are back in business injecting their garbage into everyone while their issue with 'blood clots' has still not been resolved!

Well, apparently the pricks over at AstraZeneca are not alone in the horrible adverse effects from their deadly KILL SHOTS, for according to the following article, from Tyler Durden through the Zero Hedge website, at www.zerohedge.com, apparently the deadly KILL SHOTS produced by the criminals over at Johnson & Johnson have just made the headline, as these concoctions have been causing horrific blood clots in victims as well.... Here is that article, and I have further thoughts and comments to follow:

US Calls For Pause On J&J COVID Vaccine Due To Deadly Blood Clots

Tyler Durden's Photo
BY TYLER DURDEN
TUESDAY, APR 13, 2021 - 02:12 PM

Update (1010ET): The health officials who spoke on today's call started by reiterating details about the decision to halt the J&J shared with the press earlier. Officials said they would update doctors with new vaccine "fact sheets" designated certain medications that could be associated with higher risks of blood clots.

After they said they were only seeing symptoms in patients who received the JNJ vaccine, the first question from the press (asked by an FT reporter) was: what about AstraZeneca? In Europe, governments have been imposing age limits on who can receive the AstraZeneca jab for similar reasons.

Officials responded by brushing the AZ question aside, before saying they hoped the halt would last for only a few days. Pressed about what's causing the clots, doctors said that an extremely rare immune response triggers the blood clots by sending signals in patients' blood to clot. While they said they hadn't seen complications with other vaccines, Dr. Marks said the US believes the problem in the JNJ and AZ vaccines is "related" to the adenovirus platform, though he didn't offer much in the way of details.

At one point, Dr. Marks said "the real thing that is so notable here is not just the cerebral blood clods...it's their occurrence together that makes a pattern, and that pattern is very very similar to what was seen with another vaccine."

A reporter for CNN mentioned that they were being told that this was something being "looked into" earlier, and Schuchat explained that the CDC had first looked into how best to advise the health-care community to treat and respond.

The FDA left open the possibility that new cases of blood clots could be brought to its attention. The FDA will actively search for vaccines. New guidance to be issued will help educate doctors and other health-care professionals about risk factors that could put patients at risk of the autoimmune reaction.

After offering examples of symptoms that would be on the list of potential warning signs, Dr. Marks was pressed to open up a bit more about symptoms after a doctor who was on the call asked him about specific symptoms seen by these patients. The doctor noted that listing "headaches" on a list of suspect symptoms or "abdominal pain" could lead to a lot more tests and doctor visits. At this, Marks seemed to have trouble putting a figure on the background rate of blood clots, and other questions about the prevalence of symptoms that could be seen on the FDA's list.

"This is going to translate to a lot more doctors visits for people like me," the doctor said.

The press briefing was ended soon after. Of course, it's not difficult to understand why the FDA was starting to feel uncomfortable. A wave of patients being told to seek emergency care as a precaution could push ER occupancy rates higher again. Suddenly, the numbers will be telling us that we are back in the worst of the COVID pandemic.


* * *

Update (0955ET): The FDA is holding its joint media call led by Director Peter Marks of the FDA Center for Biologics Evaluation and Research, Acting FDA Commissioner Janet Woodcock and Principle Deputy Director Anne Schuchat.


Update (0945ET): The White House is playing down the JNJ news, reiterating the earlier government claims that the overall timeline of the rollout won't be impacted.

"This announcement will not have a significant impact on our vaccination plan: Johnson & Johnson vaccine makes up less than 5% of the recorded shots in arms in the United States to date," Zients said.

US has enough Pfizer, Moderna vaccines to continue current pace of vaccinations and meet President Biden’s goal of 200 million shots by his 100th day in office.

White House is working with state and federal partners to get patients who had been scheduled for J&J vaccine rescheduled for Pfizer or Moderna.

Meanwhile, a press conference with the FDA to discuss the findings is scheduled to start in 8 minutes.

* * *

Update (0935ET): In a sign that vaccine-makers are now releasing statements simply to reassure the public that there's nothing wrong with their product, Moderna issued a statement reminder the world that "a comprehensive assessment of safety data" found no connection found no negative health drawbacks.

Stocks, so far at least, have mostly shrugged off the news, possibly finding solace in the CDC and FDA's guarantees that this won't impact the US vaccination timeline, with "the vast majority" of American adults expected to be vaccinated by the summer.

* * *

Update (0920ET): As we wait to hear more about the blood clots, JNJ just released a statement saying that after reviewing the findings with European regulators, the company would "proactively delay the rollout of our vaccine in Europe."

The safety and well-being of the people who use our products is our number one priority. We are aware of an extremely rare disorder involving people with blood clots in combination with low platelets in a small number of individuals who have received our COVID-19 vaccine. The United States Centers for Disease Control (CDC) and Food and Drug Administration (FDA) are reviewing data involving six reported U.S. cases out of more than 6.8 million doses administered. Out of an abundance of caution, the CDC and FDA have recommended a pause in the use of our vaccine.

In addition, we have been reviewing these cases with European health authorities. We have made the decision to proactively delay the rollout of our vaccine in Europe.

We have been working closely with medical experts and health authorities, and we strongly support the open communication of this information to healthcare professionals and the public.

The CDC and FDA have made information available about proper recognition and management due to the unique treatment required with this type of blood clot. The health authorities advise that people who have received our COVID-19 vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.

Meanwhile, any patients who were set to be vaccinated at New York State's mass vaccination sites will receive Pfizer jabs instead of the J&J shots, said Health Commissioner Howard Zucker, as Gov. Andrew Cuomo has promised to honor all vaccination appointments.

While cities will likely be able to make things work by rescheduling some second-dose appointments, rural areas, where the JNJ jab was supposed to be a major difference-maker due to the requirement for only one shot.

As we wait to hear more from other national regulators, a drugs regulator in the Netherlands, which halted use of the AstraZeneca jab earlier this month, said Tuesday that the benefits of the JNJ jab outweigh the risks.

* * *

Update (0740ET): A press briefing will be held at 1000ET to share more details of the JNJ situation. A joint statement has been released by the CDC and FDA.

The following statement is attributed to Dr. Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research and Dr. Anne Schuchat, Principal Deputy Director of the CDC.

A meeting of the Advisory Committee on Immunization Practices will also be called on Wednesday to further examine the situation.

As of April 12, more than 6.8 million doses of the Johnson & Johnson (Janssen) vaccine have been administered in the U.S. CDC and FDA are reviewing data involving six reported U.S. cases of a rare and severe type of blood clot in individuals after receiving the J&J vaccine. In these cases, a type of blood clot called cerebral venous sinus thrombosis (CVST) was seen in combination with low levels of blood platelets (thrombocytopenia). All six cases occurred among women between the ages of 18 and 48, and symptoms occurred 6 to 13 days after vaccination. Treatment of this specific type of blood clot is different from the treatment that might typically be administered. Usually, an anticoagulant drug called heparin is used to treat blood clots. In this setting, administration of heparin may be dangerous, and alternative treatments need to be given.

CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases. Until that process is complete, we are recommending a pause in the use of this vaccine out of an abundance of caution. This is important, in part, to ensure that the health care provider community is aware of the potential for these adverse events and can plan for proper recognition and management due to the unique treatment required with this type of blood clot.

Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider. Health care providers are asked to report adverse events to the Vaccine Adverse Event Reporting System.

CDC and FDA will provide additional information and answer questions later today at a media briefing. A recording of that media call will be available on the FDA’s YouTube channel.

Meanwhile, across Wall Street, everybody is trying to figure out exactly what this means for markets and the Fed. Like every other bit of vaccine-related news to date, we suspect the answer is "unambiguously bullish".

* * *

In a shocking report that could have dramatic implications for the US vaccine rollout, federal public health authorities in the US have decided to stop administering COVID jabs developed by Johnson & Johnson, and are asking states to do the same. The reason? Authorities have identified six cases of rare and life-threatening blood clots, at least one of which resulted in death.

According to the NYT, which broke the news, all six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition, the officials said.

The FDA published its own advisory shortly after the NYT broke the news.

All federal facilities will halt use of the jab immediately, and the states are expected to follow suit by ordering jabs to be suspended at their vaccination site. Regardless, we imagine most Americans would refuse a JNJ jab now that reports of the blood clots, which also were found to be associated with AstraZeneca vaccines by authorities in Europe.

Federal health agencies on Tuesday will call for an immediate pause in use of Johnson & Johnson’s single-dose coronavirus vaccine after six recipients in the United States developed a rare disorder involving blood clots within about two weeks of vaccination, officials briefed on the decision said.

All six recipients were women between the ages of 18 and 48. One woman died and a second woman in Nebraska has been hospitalized in critical condition, the officials said.

Nearly seven million people in the United States have received Johnson & Johnson shots so far, and roughly nine million more doses have been shipped out to the states, according to data from the Centers for Disease Control and Prevention.

While the move is framed as a recommendation to health practitioners in the states, the federal government is expected to pause administration of the vaccine at all federally run vaccination sites. Federal officials expect that state health officials will take that as a strong signal to do the same.

The FDA and CDC will jointly examine any potential link between the vaccines and the blood clots. The decision to halt the rollout could ""substantially complicate" the country's vaccination trajectory, and already, markets are looking shakey.

Scientists with the Food and Drug Administration and C.D.C. will jointly examine possible links between the vaccine and the disorder and determine whether the F.D.A. should continue to authorize use of the vaccine for all adults or limit the authorization. An emergency meeting of the C.D.C.’s outside advisory committee has been scheduled for Wednesday, officials said.

An F.D.A. spokeswoman declined to comment.

The move could substantially complicate the nation’s vaccination efforts at a time when many states are confronting a surge in new cases and seeking to address vaccine hesitancy. Regulators in Europe and elsewhere are concerned about a similar issue with another coronavirus vaccine, developed by AstraZeneca and Oxford University researchers. That concern has driven up some resistance to all vaccines, even though the AstraZeneca version has not been approved for use in the United States.

Supply disruptions at a US factory in Baltimore coincidentally led to a dramatic reduction in supply of Johnson & Johnson vaccines on the market, leading to shortages that prompted a brief slowdown in the US vaccine rollout.Nearly 7 million people have received the JNJ jab so far in the US, and roughly 9 million more doses have been shipped. Fortunately, most of the vaccines distributed so far in the US were manufactured by Moderna and Pfizer-BioNTech. Still, the Biden Administration had been counting on using hundreds of thousands of JNJ doses per week. And what's more, the jab - which had the advantage of being doled out in a single dose, as opposed to multiple doses for Pfizer and Moderna - was supposed to play an important role in helping Europe catch up to the US and UK.

As for how this might set back the Biden Administration's push to vaccinate the US, "it's unclear." In the US alone, 300K to 600K people a year develop blood clots, according to CDC data. But the particular blood clotting disorder that the vaccine recipients developed, known as cerebral venous thrombosis, is extremely rare. What's more, it's the same disorder linked to jabs produced by AstraZeneca in Europe.

Out of 34M people who received the vaccine in Britain, the European Union and three other countries, only 222 experienced blood clots, and in those cases, the clotting was linked with low levels of platelets. The majority of these cases occurred within the first 14 days following vaccination, mostly in women under 60 years of age.

Like AstraZeneca, JNJ uses the adenovirus platform for its jabs, which, as it happens, was the reason Australia cited when it announced Tuesday overnight that it wouldn't purchase the JNJ jabs for domestic use.

NTS Notes: Honestly... WHY should anyone be surprised by this revelation and how the pricks at Johnson & Johnson have pushed this garbage on the general public and probably knowing full well that it would indeed have horrible adverse effects?

I also saw some information where the pricks at Johnson & Johnson claim that they saw none of these 'effects' in their 'clinical trials' on this garbage.. But I have a huge question here regarding their 'clinical trials' statements where there is NO evidence that any real clinical trials were really conducted with success.... Much like the pricks over at Pfizer and Moderna that claim that they also conducted clinical trials but were caught lying their asses off, I would assume that Johnson & Johnson as well as AstraZeneca did ZERO real trials and basically rushed their crap to market just to use human beings like guinea pigs in a 'clinical trial' that is going on right now with the millions already shot up with their garbage which supposedly will not end until 2023....

And about their 'blood clot' numbers... If you assume like all of the other horrible adverse effects that they are downplaying and giving only about 5-10% accuracy in their reports, then this '6' reported blood clot cases is only those that have been reported, and we can safely assume that the real toll is probably in the hundreds if not higher....

So, once again I do have to ask WHY IN THE HELL are people out there still begging to have this crap injected into their bodies that will either cripple them permanently immediately or have them die a slow painful death for 3-6 months before their brains are turned to mush via Mad Cow Disease, or worse?   I for one just cannot even understand humanity any more and how so many are simply this brain dead or  so easily brainwashed...

And things only go from bad to worse for these criminal Pharmaceutical pricks and their KILL SHOTS... For I was alerted earlier to a new article that comes from my fellow Canadian real truth seeker, Penny, who writes her blog over at "Penny For Your Thoughts" at www.pennyforyourthoughts2.blogspot.com, where apparently CANADA, where the assholes responsible for Canada Health under the Trudeau Liberal regime,  had indeed approved the AstraZeneca KILL SHOTS for injection into Canadians in spite of the blood clotting problem, has recorded what they claim is their 'first case' of AstraZeneca caused blood clotting!  Here is the link to Penny's article here:

http://pennyforyourthoughts2.blogspot.com/2021/04/canadas-first-case-of-astra-zenecacovi.html

Thanks to Penny for that report....

And NO shock to me at all from what I am seeing still happen with the garbage from AstraZeneca.... And this may again just be one of many that have come down with this blood clotting issue here in Canada... This does indeed put egg on the face of that prick,  Justin Trudeau, who less than a month ago went on Canadian national TALMUDVISION declaring that the KILL SHOTS from AstraZeneca were 'safe'....

I have an idea; If Trudeau and his criminals pushing these genocidal KILL SHOTS in Canada are saying that their jabs of death are safe, then lets use THEM in a real 'clinical trial' where we give them these KILL SHOTS (and no placebos) and see after a few months how THEY react..... It would probably not be a pretty picture at all and may finally wake up a lot of Canadians to the truth about these shots of certain death.

More to come

NTS

2 comments:

Barney said...

Six cases? SIX? I've got a one-word answer to that, but it's not very polite, so I'll just say men have two of them.

Could it be that J&J have volunteered to be the "bad guys" in this scam? Create something that's even worse than the A-Z one, let it be known how bad it is, then have it withdrawn to show (((they))) really do care about keeping us safe?

"See? We had a few - very minor - doubts about this one, so we withdrew it to reassure the public. The adverse effects are extremely rare, but we can't take chances with public health. Now you can confidently line up like good little sheeple and take the much safer poisons offered by our competitors".

A bit of psychology at work there I suspect. The "British" (((government))) has an entire department whose job it is to reinforce the fear of the imaginary disease while attempting to reassure us that "vaccines", and especially this fake one, are "95% safe and effective", the lying bastards.

Adverse effects are always "extremely rare", and if you believe that, I've got a nice-looking bridge in London I can let you have at a bargain price.

This was never about a disease. They invaded and terrorised Russia from 1917, murdering a possible 100 million Human Beings, often in "imaginative" ways, and now they're attempting to use an imaginary disease as cover for a worldwide power grab that - if successful - will make every Human wish they'd never been born.

I specify Human because the (((devils))) behind this scam are not human. They lack empathy, compassion, Love, appreciation of beauty, everything that makes people Human. All they know is hatred and extreme sadism, deriving satisfaction from the suffering of others, whether Human or otherwise. That's why I say these willing servants of the devil are not Human.

Even the so-called "lesser beings", the various "animal" species, show more Human-like behaviour than the devil's gargoyles, such as the cat I once knew that repeatedly went down into the burrow to rescue orphaned baby rabbits, bringing them out one at a time. All species care more for others than the devil known as "jew".

Unknown said...

The Jews have been called "the Devil's children."